Protease inhibitors
Invirase
The FDA lists this product in 2 strengths and forms.
Composition
- Active ingredients
- SAQUINAVIR MESYLATE EQ 500MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SAQUINAVIR MESYLATE EQ 500MG BASE · TabletThis page
- SAQUINAVIR MESYLATE EQ 200MG BASE · CapsuleNDA020628-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021785.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Invirase
- Active substance
- saquinavir mesylate
- Drug class
- Protease inhibitors
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Hoffmann-LA Roche
- Status
- Discontinued
- FDA approval
- 17 Dec 2004
- Application
- NDA021785-001
- RxCUI
- 859857